Oliver Ast

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 342 citations · Full text

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 271 citations · Full text

Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity

Sabine Hoves, Chia-Huey Ooi, Carsten Wolter et al. · The Journal of Experimental Medicine · 2018 · 205 citations · Full text

Rapid Activation, Immune Evasion, Cancer Immunosurveillance +14

A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease

Laurence B. Peterson, Sarah Howlett, Marcin Ł. Pękalski et al. · Journal of Autoimmunity · 2018 · 140 citations · Full text

Molecular Cloning and Expression of Major Structural Protein VP1 of the Human Polyomavirus JC Virus: Formation of Virus-Like Particles Useful for Immunological and Therapeutic Studies

Claudia Goldmann, Harald Petry, Stephan A. Frye et al. · Journal of Virology · 1999 · 125 citations · Full text